Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma

Katy Mastorci, Barbara Montico, Damiana A. Faè, Luca Sigalotti, Maurilio Ponzoni, Giorgio Inghirami, Riccardo Dolcetti, Jessica Dal Col

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-β combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-β combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-β, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by coimmunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-β strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-β-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy.

Original languageEnglish
Pages (from-to)41913-41928
Number of pages16
JournalOncotarget
Volume7
Issue number27
Publication statusPublished - May 26 2016

Fingerprint

Phospholipid Transfer Proteins
Mantle-Cell Lymphoma
Autophagy
Apoptosis
Interferons
Tretinoin
Up-Regulation
Protective Agents
Hematologic Neoplasms
Membrane Lipids
Doxorubicin
Proteins
Pharmacology
Biopsy
Cell Line

Keywords

  • Apoptosis
  • Autophagy
  • Interferon-α
  • Mantle cell lymphoma
  • Phospholipid scramblase 1

ASJC Scopus subject areas

  • Oncology

Cite this

Mastorci, K., Montico, B., Faè, D. A., Sigalotti, L., Ponzoni, M., Inghirami, G., ... Dal Col, J. (2016). Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma. Oncotarget, 7(27), 41913-41928.

Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma. / Mastorci, Katy; Montico, Barbara; Faè, Damiana A.; Sigalotti, Luca; Ponzoni, Maurilio; Inghirami, Giorgio; Dolcetti, Riccardo; Dal Col, Jessica.

In: Oncotarget, Vol. 7, No. 27, 26.05.2016, p. 41913-41928.

Research output: Contribution to journalArticle

Mastorci, Katy ; Montico, Barbara ; Faè, Damiana A. ; Sigalotti, Luca ; Ponzoni, Maurilio ; Inghirami, Giorgio ; Dolcetti, Riccardo ; Dal Col, Jessica. / Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma. In: Oncotarget. 2016 ; Vol. 7, No. 27. pp. 41913-41928.
@article{7d9a124fe7174e37b2354f62540048f5,
title = "Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma",
abstract = "Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-β combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-β combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-β, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by coimmunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-β strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-β-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy.",
keywords = "Apoptosis, Autophagy, Interferon-α, Mantle cell lymphoma, Phospholipid scramblase 1",
author = "Katy Mastorci and Barbara Montico and Fa{\`e}, {Damiana A.} and Luca Sigalotti and Maurilio Ponzoni and Giorgio Inghirami and Riccardo Dolcetti and {Dal Col}, Jessica",
year = "2016",
month = "5",
day = "26",
language = "English",
volume = "7",
pages = "41913--41928",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "27",

}

TY - JOUR

T1 - Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma

AU - Mastorci, Katy

AU - Montico, Barbara

AU - Faè, Damiana A.

AU - Sigalotti, Luca

AU - Ponzoni, Maurilio

AU - Inghirami, Giorgio

AU - Dolcetti, Riccardo

AU - Dal Col, Jessica

PY - 2016/5/26

Y1 - 2016/5/26

N2 - Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-β combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-β combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-β, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by coimmunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-β strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-β-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy.

AB - Mantle cell lymphoma (MCL) is an aggressive haematological malignancy in which the response to therapy can be limited by aberrantly activated molecular and cellular pathways, among which autophagy was recently listed. Our study shows that the 9-cis-retinoic acid (RA)/Interferon(IFN)-β combination induces protective autophagy in MCL cell lines and primary cultures reducing the extent of drug-induced apoptosis. The treatment significantly up-regulates phospholipid scramblase 1 (PLSCR1), a protein which bi-directionally flips lipids across membranes. In particular, RA/IFN-β combination concomitantly increases PLSCR1 transcription and controls PLSCR1 protein levels via lysosomal degradation. Herein we describe a new function for PLSCR1 as negative regulator of autophagy. Indeed, PLSCR1 overexpression reduced MCL cell susceptibility to autophagy induced by RA/IFN-β, serum deprivation or mTOR pharmacological inhibition. Moreover, PLSCR1 can bind the ATG12/ATG5 complex preventing ATG16L1 recruitment and its full activation, as indicated by coimmunoprecipitation experiments. The combination of doxorubicin or bortezomib with RA/IFN-β strengthened PLSCR1 up-regulation and enhanced apoptosis, as a likely consequence of the blockade of RA/IFN-β-induced autophagy. Immunohistochemical analysis of 32 MCL biopsies revealed heterogeneous expression of PLSCR1 and suggests its possible implication in the response to anticancer therapies, especially to drugs promoting protective autophagy.

KW - Apoptosis

KW - Autophagy

KW - Interferon-α

KW - Mantle cell lymphoma

KW - Phospholipid scramblase 1

UR - http://www.scopus.com/inward/record.url?scp=84991407906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991407906&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 41913

EP - 41928

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 27

ER -